Key statistics
As of last trade AbbVie Inc (4ABX:GER) traded at 164.48, -14.56% below its 52-week high of 192.50, set on Nov 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 164.04 |
---|---|
High | 164.48 |
Low | 164.04 |
Bid | 163.78 |
Offer | 164.48 |
Previous close | 162.74 |
Average volume | 2.57k |
---|---|
Shares outstanding | 1.77bn |
Free float | 1.77bn |
P/E (TTM) | 59.91 |
Market cap | 303.47bn USD |
EPS (TTM) | 2.87 USD |
Annual div (ADY) | 6.26 EUR |
---|---|
Annual div yield (ADY) | 3.82% |
Div ex-date | Oct 15 2024 |
Div pay-date | Nov 15 2024 |
Next div ex-date | Jan 15 2025 |
Next div pay-date | Feb 14 2025 |
Data delayed at least 15 minutes, as of Nov 22 2024 08:32 GMT.
More ▼
Press releases
- PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
- Seaport Therapeutics Names Lauren White as Chief Financial Officer
- NImmune Biopharma Announces R&D Collaboration with BioTherapeutics, Inc. to Advance the Next Wave of Inflammation and Immunology Precision Medicines